Aurora specializes in minimally-invasive, regenerative technologies. Our mission is to be the leader in advanced spinal technologies which will have a positive impact on lives worldwide.


There are hundreds of companies in this industry all striving to bridge the gap between patient satisfaction and clinical success. Aurora Spine was formed to bridge that gap and bring innovation to minimally-invasive surgery, regenerative medicine, and the aging patient. Our philosophy is to make our implants match the patient's anatomy, not to make their anatomy fit our implants. We are committed to make our implants better, less invasive, and most importantly something that truly helps the patient and improves their quality of life. Innovation targeted at our patients' well-being.


Board Chairmain

Board Chairmain

David Rosenkrantz

Board Member

Board Member

Jim Snow

Board Member

Board Member

Mike Seid

Board Member

Board Member

Daryl Maclellan

Board Member

Board Member

Tracy Graf




Trent Northcutt - Chief Executive Officer & BOARD MEMBER

Mr. Northcutt posesses over 19 years of experience in the medical device market. He has a proven track record of building dynamic and highly successful early stage start-up companies. From 2003 to 2007, Mr. Northcutt served as the VP of Sales and Business Development for Alphatec Spine, Inc., responsible for strategic sales development, M&A, and training. During his tenure, the company’s revenues increased from $7.0 million to $87.1 million, and on June 12th, 2006 he helped take Alphatec public on NASDAQ (ATEC).

In 2007, Mr. Northcutt as Vice President, Sales and Operations at Lanx, LLC, raised $25 million and launched the Aspen ISP fusion device, increasing revenues from $6.4 to $48.9 million. Then in 2009, Mr. Northcutt successfully launched the North American operation for Spineart USA, Inc., where he served as Vice President and produced revenues from $0 to $12.7 million in three years.

Mr. Northcutt holds a degree in Surgical Technology (CST-CFA) from Glendale University in Glendale, California.


Laszlo GaramszegI - Chief Technology Officer

Mr. Garamszegi brings over 19 years of executive experience in the medical device industry. He has co-founded several, successful medical device start-up companies, where he then served as Chief Technology Officer and VP of Engineering. He established the Product Development, Quality, Regulatory, and Manufacturing departments for his companies, and during this time he launched numerous CE Marked and over13 FDA 510(k)-cleared implant products.

Mr. Garamszegi is a co-inventor of the ZIP® interspinous implant product line. He has also been awarded eleven United States and one Canadian patent for his spinal implant designs and has several other patents pending; most of these inventions were commercialized and currently being sold in the United States, Canada, Europe and other international markets.  Laszlo is the co-inventor of the 4Closure℣ Laparoscopic Fascia Closure Device, a technology that was sold to Synovis Life Technologies in 2007 (NYSE: SYNO) then to Baxter International (NYSE: BAX).

Mr. Garamszegi received his Manufacturing Engineering Technology degree from Banki Donat Technical Institute in Hungary.



David has 25 years of legal experience and over 30 years of business experience to draw from. David has owned his own firm and practiced with large and small law firms and as in-house general counsel. David has also spent time on the client side of the table, serving as Chief Operating Officer for the Anthony Robbins Companies from 2006-2008, a period of rapid growth for the company headed by peak performance speaker, Tony Robbins.

David specializes in business, corporate, real estate acquisition, sale and leasing, franchising and licensing matters. David has represented clients such as Ross Dress for Less, Gymboree, Chevy’s, Pulte Homes, the Oakland Alameda County Coliseum and Carruth Cellars.



Ms. Mason brings more than 16 years of corporate finance experience to Aurora Spine. Prior to Joining Aurora Spine, Ms. Mason was Director of Accounting & Finance at International Stem Cell Corp., a publicly traded company. Ms. Mason began her career with Ernst and Young working primarily in the Assurance and Advisory Business Services group. Ms. Mason earned a Bachelor of Science in Accounting from San Diego State University.